CG Oncology (CGON) Shares Issued (2023 - 2026)

CG Oncology has reported Shares Issued for 4 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 144.72% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $148.8 million (up 182.51% YoY), and the FY2025 full-year result was $147.4 million, down 63.72% from the prior year.
• Shares Issued for Q1 2026 stood at $1.7 million, down from $98.4 million in the prior quarter.
• The five-year high for Shares Issued was $406.4 million in Q1 2024, with the low at -$406.3 million in Q2 2024.
• Historically, Shares Issued has averaged $29.0 million across 4 years, with a median of $1.6 million in 2023.
• The largest YoY upside for Shares Issued was 597561.76% in 2024 against a maximum downside of 246362.42% in 2024.
• CG Oncology's Shares Issued stood at $262000.0 in 2023, then soared by 85052.67% to $223.1 million in 2024, then slumped by 55.87% to $98.4 million in 2025, then slumped by 98.3% to $1.7 million in 2026.
• The last three Shares Issued figures came in at $1.7 million (Q1 2026), $98.4 million (Q4 2025), and $48.7 million (Q3 2025), per Business Quant data.